Gender Differences in Risk Factors for Aberrant Prescription Opioid Use

Robert N. Jamison, Stephen F. Butler, Simon H. Budman, Robert R. Edwards, Ajay D. Wasan

Research output: Contribution to journalArticle

Abstract

This is a longitudinal predictive study to examine gender differences in the clinical correlates of risk for opioid misuse among chronic pain patients prescribed opioids for pain. Two hundred seventy-five male and 335 female patients prescribed opioids for chronic noncancer pain were asked to complete a series of baseline questionnaires, including the revised Screener and Opioid Assessment for Pain Patients (SOAPP-R). After 5 months, the subjects were administered a structured prescription drug use interview (Prescription Drug Use Questionnaire; PDUQ) and submitted a urine sample for toxicology assessment. Their treating physicians also completed a substance misuse behavior checklist (Prescription Opioid Therapy Questionnaire; POTQ). At 5-month follow-up, women showed higher scores on the PDUQ (P <.05), whereas men had a higher incidence of physician-rated aberrant drug behavior on the POTQ (P <.05). An item analysis of the SOAPP-R, PDUQ, and POTQ showed that women tended to score higher on items relating to psychological distress, whereas the male patients tended to report having more legal and behavioral problems. These results suggest that risk factors associated with prescription opioid misuse may differ between men and women. Perspective: Understanding gender differences in substance abuse risk among chronic pain patients is important for clinical assessment and treatment. This study suggests that women are at greater risk to misuse opioids because of emotional issues and affective distress, whereas men tend to misuse opioids because of legal and problematic behavioral issues.

Original languageEnglish (US)
Pages (from-to)312-320
Number of pages9
JournalJournal of Pain
Volume11
Issue number4
DOIs
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

Opioid Analgesics
Prescriptions
Chronic Pain
Prescription Drugs
Physicians
Pain Measurement
Checklist
Toxicology
Substance-Related Disorders
Longitudinal Studies
Urine
Interviews
Psychology
Pain
Incidence
Therapeutics
Pharmaceutical Preparations
Surveys and Questionnaires

Keywords

  • aberrant drug behaviors
  • addiction
  • chronic pain
  • Gender differences
  • opioids
  • substance abuse

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Neurology
  • Clinical Neurology

Cite this

Jamison, R. N., Butler, S. F., Budman, S. H., Edwards, R. R., & Wasan, A. D. (2010). Gender Differences in Risk Factors for Aberrant Prescription Opioid Use. Journal of Pain, 11(4), 312-320. https://doi.org/10.1016/j.jpain.2009.07.016

Gender Differences in Risk Factors for Aberrant Prescription Opioid Use. / Jamison, Robert N.; Butler, Stephen F.; Budman, Simon H.; Edwards, Robert R.; Wasan, Ajay D.

In: Journal of Pain, Vol. 11, No. 4, 04.2010, p. 312-320.

Research output: Contribution to journalArticle

Jamison, RN, Butler, SF, Budman, SH, Edwards, RR & Wasan, AD 2010, 'Gender Differences in Risk Factors for Aberrant Prescription Opioid Use', Journal of Pain, vol. 11, no. 4, pp. 312-320. https://doi.org/10.1016/j.jpain.2009.07.016
Jamison, Robert N. ; Butler, Stephen F. ; Budman, Simon H. ; Edwards, Robert R. ; Wasan, Ajay D. / Gender Differences in Risk Factors for Aberrant Prescription Opioid Use. In: Journal of Pain. 2010 ; Vol. 11, No. 4. pp. 312-320.
@article{41a4899b275f464b9b7bb58e103c8f13,
title = "Gender Differences in Risk Factors for Aberrant Prescription Opioid Use",
abstract = "This is a longitudinal predictive study to examine gender differences in the clinical correlates of risk for opioid misuse among chronic pain patients prescribed opioids for pain. Two hundred seventy-five male and 335 female patients prescribed opioids for chronic noncancer pain were asked to complete a series of baseline questionnaires, including the revised Screener and Opioid Assessment for Pain Patients (SOAPP-R). After 5 months, the subjects were administered a structured prescription drug use interview (Prescription Drug Use Questionnaire; PDUQ) and submitted a urine sample for toxicology assessment. Their treating physicians also completed a substance misuse behavior checklist (Prescription Opioid Therapy Questionnaire; POTQ). At 5-month follow-up, women showed higher scores on the PDUQ (P <.05), whereas men had a higher incidence of physician-rated aberrant drug behavior on the POTQ (P <.05). An item analysis of the SOAPP-R, PDUQ, and POTQ showed that women tended to score higher on items relating to psychological distress, whereas the male patients tended to report having more legal and behavioral problems. These results suggest that risk factors associated with prescription opioid misuse may differ between men and women. Perspective: Understanding gender differences in substance abuse risk among chronic pain patients is important for clinical assessment and treatment. This study suggests that women are at greater risk to misuse opioids because of emotional issues and affective distress, whereas men tend to misuse opioids because of legal and problematic behavioral issues.",
keywords = "aberrant drug behaviors, addiction, chronic pain, Gender differences, opioids, substance abuse",
author = "Jamison, {Robert N.} and Butler, {Stephen F.} and Budman, {Simon H.} and Edwards, {Robert R.} and Wasan, {Ajay D.}",
year = "2010",
month = "4",
doi = "10.1016/j.jpain.2009.07.016",
language = "English (US)",
volume = "11",
pages = "312--320",
journal = "Journal of Pain",
issn = "1526-5900",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Gender Differences in Risk Factors for Aberrant Prescription Opioid Use

AU - Jamison, Robert N.

AU - Butler, Stephen F.

AU - Budman, Simon H.

AU - Edwards, Robert R.

AU - Wasan, Ajay D.

PY - 2010/4

Y1 - 2010/4

N2 - This is a longitudinal predictive study to examine gender differences in the clinical correlates of risk for opioid misuse among chronic pain patients prescribed opioids for pain. Two hundred seventy-five male and 335 female patients prescribed opioids for chronic noncancer pain were asked to complete a series of baseline questionnaires, including the revised Screener and Opioid Assessment for Pain Patients (SOAPP-R). After 5 months, the subjects were administered a structured prescription drug use interview (Prescription Drug Use Questionnaire; PDUQ) and submitted a urine sample for toxicology assessment. Their treating physicians also completed a substance misuse behavior checklist (Prescription Opioid Therapy Questionnaire; POTQ). At 5-month follow-up, women showed higher scores on the PDUQ (P <.05), whereas men had a higher incidence of physician-rated aberrant drug behavior on the POTQ (P <.05). An item analysis of the SOAPP-R, PDUQ, and POTQ showed that women tended to score higher on items relating to psychological distress, whereas the male patients tended to report having more legal and behavioral problems. These results suggest that risk factors associated with prescription opioid misuse may differ between men and women. Perspective: Understanding gender differences in substance abuse risk among chronic pain patients is important for clinical assessment and treatment. This study suggests that women are at greater risk to misuse opioids because of emotional issues and affective distress, whereas men tend to misuse opioids because of legal and problematic behavioral issues.

AB - This is a longitudinal predictive study to examine gender differences in the clinical correlates of risk for opioid misuse among chronic pain patients prescribed opioids for pain. Two hundred seventy-five male and 335 female patients prescribed opioids for chronic noncancer pain were asked to complete a series of baseline questionnaires, including the revised Screener and Opioid Assessment for Pain Patients (SOAPP-R). After 5 months, the subjects were administered a structured prescription drug use interview (Prescription Drug Use Questionnaire; PDUQ) and submitted a urine sample for toxicology assessment. Their treating physicians also completed a substance misuse behavior checklist (Prescription Opioid Therapy Questionnaire; POTQ). At 5-month follow-up, women showed higher scores on the PDUQ (P <.05), whereas men had a higher incidence of physician-rated aberrant drug behavior on the POTQ (P <.05). An item analysis of the SOAPP-R, PDUQ, and POTQ showed that women tended to score higher on items relating to psychological distress, whereas the male patients tended to report having more legal and behavioral problems. These results suggest that risk factors associated with prescription opioid misuse may differ between men and women. Perspective: Understanding gender differences in substance abuse risk among chronic pain patients is important for clinical assessment and treatment. This study suggests that women are at greater risk to misuse opioids because of emotional issues and affective distress, whereas men tend to misuse opioids because of legal and problematic behavioral issues.

KW - aberrant drug behaviors

KW - addiction

KW - chronic pain

KW - Gender differences

KW - opioids

KW - substance abuse

UR - http://www.scopus.com/inward/record.url?scp=77949913428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949913428&partnerID=8YFLogxK

U2 - 10.1016/j.jpain.2009.07.016

DO - 10.1016/j.jpain.2009.07.016

M3 - Article

C2 - 19944648

AN - SCOPUS:77949913428

VL - 11

SP - 312

EP - 320

JO - Journal of Pain

JF - Journal of Pain

SN - 1526-5900

IS - 4

ER -